Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New DNA test for glaucoma-causing mutation in border collies
“Our research has found that the mutation is only associated with glaucoma in border collies."
Scientists identify variant in the gene OLFML3 

The Animal Health Trust has launched a new DNA test for the genetic mutation that causes glaucoma in border collies.

Scientists from the Roslin Institute originally identified a variant in the gene OLFML3, which is associated with severe goniodysgenesis and glaucoma in this dog breed.

On reading the research, the Animal Health Trust’s genetics team genotyped a large cohort of border collies for the mutation, which allowed the team to obtain an accurate measure of the association between the mutation and goniodysgenesis and glaucoma. All dogs were also given an eye examination and had DNA collected.

The new test was developed and launched following this validation process, which replicated the findings from the Roslin Institute. Breeders will now be able to use the test to reduce the risk of producing puppies affected with glaucoma, which affects more than 1,000 dogs across the UK.

Dr Cathryn Mellersh, head of canine genetics at the Animal Health Trust, said: “We’re delighted to offer this test to border collie breeders and hope in time, through its use, we can lessen the prevalence of this disease in this lovely breed.
 
“Our research has found that the mutation is only associated with glaucoma in border collies, so we will publish our data at the earliest opportunity, in the hope that other commercial DNA testing providers will not be tempted to make the DNA test available to breeds other than the border collie.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.